Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Miltenyi Biomedicine GmbH
Mayo Clinic
Daiichi Sankyo
Seagen Inc.
Alexion Pharmaceuticals, Inc.
Fundación Academia Española de Dermatología
Hospices Civils de Lyon
Rhizen Pharmaceuticals SA
Seagen Inc.